RCA
LLY icon

Riverview Capital Advisers’s Eli Lilly LLY Stock Holding History

Riverview Capital Advisers’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$605K Sell
504
-5
-1% -$5.11K 0.17% 55
2026
Q1 		$468K Hold
509
– – 0.16% 57
2025
Q4 		$547K Buy
509
+14
+3% +$13.4K 0.17% 61
2025
Q3 		$378K Buy
+495
New +$368K 0.11% 76

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Riverview Capital Advisers's LLY Position: Q2 2026 in Review

Riverview Capital Advisers reduced its Eli Lilly (LLY) stake by 0.98% in Q2 2026, selling an estimated $5.11K and leaving 504 shares worth $605K. The position accounts for 0.17% of the portfolio, ranked #55.

Riverview Capital Advisers first reported a position in LLY in Q3 2025 and has held it in 4 quarters since. 4,633 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Riverview Capital Advisers held 504 shares of Eli Lilly worth $605K as of Q2 2026.
  • Riverview Capital Advisers sold 5 Eli Lilly shares in Q2 2026, an estimated $5.11K.
  • Eli Lilly made up 0.17% of Riverview Capital Advisers's portfolio in Q2 2026, its #55 holding.
  • Riverview Capital Advisers first reported a position in Eli Lilly in Q3 2025 and has held it in 4 quarters since.
  • 4,633 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Riverview Capital Advisers's 13F filing for Q2 2026, filed 13 Aug 2026.